Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Disparities and outcomes in the first and second year of the pandemic on events of acute myocardial infarction in COVID-19 patient

Version 1 : Received: 3 March 2024 / Approved: 3 March 2024 / Online: 4 March 2024 (09:39:13 CET)

A peer-reviewed article of this Preprint also exists.

Dhaliwal, J.S.; Sekhon, M.S.; Rajotia, A.; Dang, A.K.; Singh, P.P.; Bilal, M.; Sakthivel, H.; Ahmed, R.; Verma, R.; Ramphul, K.; Sethi, P.S. Disparities and Outcomes in the First and Second Year of the Pandemic on Events of Acute Myocardial Infarction in Coronavirus Disease 2019 Patients. Medicina 2024, 60, 597. Dhaliwal, J.S.; Sekhon, M.S.; Rajotia, A.; Dang, A.K.; Singh, P.P.; Bilal, M.; Sakthivel, H.; Ahmed, R.; Verma, R.; Ramphul, K.; Sethi, P.S. Disparities and Outcomes in the First and Second Year of the Pandemic on Events of Acute Myocardial Infarction in Coronavirus Disease 2019 Patients. Medicina 2024, 60, 597.

Abstract

Background: Coronavirus disease 2019 (COVID-19) caused several cardiovascular complications, including acute myocardial infarction(AMI) in infected patients. Our study aims to understand the overall trends of AMI among COVID-19 patients during the first two years of the pandemic and the disparities and outcomes between the first and second years. Methods: Our retrospective analysis via the 2020 and 2021 National Inpatient Sample(NIS) for hospitalizations between April 2020 and December 2021 analyzed adults with a primary diagnosis of COVID-19 who experienced events of AMI. We compared month-to-month events of AMI and mortality of AMI patients with COVID-19, patient characteristics, and outcomes between the 2020 and 2021 AMI samples. Results: There were 2,541,992 COVID-19 patients, with 3.55% experiencing AMI. The highest rate of AMI was in December 2021 (4.35%). No statistical differences in trends of AMI mortality were noted over the 21 months. AMI cases in 2021 had higher odds of undergoing PCI (aOR 1.627, p

Keywords

COVID-19; Cardiovascular complications; national inpatient sample; United States; mortality; epidemiology

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.